Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amrendra Kumar

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGYNo-Joon Song, Carter Allen, Anna E Vilgelm, et al.
Journal of Medicinal Chemistry|May 9, 2024
Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial AgentsPapireddy Kancharla, Diana Ortiz, Corinne M Fargo, et al.
Journal of Hematology & Oncology|January 11, 2022
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathologyNo-Joon Song, Carter Allen, Anna E Vilgelm, et al.
Journal of Medicinal Chemistry|June 1, 2025
Optimization of Tambjamines Active against Multiple Stages of Malaria ParasitesAmrendra Kumar, Yuexin Li, Xiaowei Zhang, et al.
ACS Infectious Diseases|November 11, 2024
Tambjamines as Fast-Acting Multistage AntimalarialsAmrendra Kumar, Yuexin Li, Rozalia A Dodean, et al.
Journal of Medicinal Chemistry|November 18, 2025
Optimization of Prodiginines as Single-Dose Curative AntimalarialsAmrendra Kumar, Yuexin Li, Xiaowei Zhang, et al.
Journal of Medicinal Chemistry|April 3, 2025
Development of Next-Generation Antimalarial Acridones with Radical Cure PotentialRozalia A Dodean, Yuexin Li, Xiaowei Zhang, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGYNo-Joon Song, Carter Allen, Anna E Vilgelm, et al.
Journal of Medicinal Chemistry|May 9, 2024
Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial AgentsPapireddy Kancharla, Diana Ortiz, Corinne M Fargo, et al.
Journal of Hematology & Oncology|January 11, 2022
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathologyNo-Joon Song, Carter Allen, Anna E Vilgelm, et al.
Journal of Medicinal Chemistry|June 1, 2025
Optimization of Tambjamines Active against Multiple Stages of Malaria ParasitesAmrendra Kumar, Yuexin Li, Xiaowei Zhang, et al.
ACS Infectious Diseases|November 11, 2024
Tambjamines as Fast-Acting Multistage AntimalarialsAmrendra Kumar, Yuexin Li, Rozalia A Dodean, et al.
Journal of Medicinal Chemistry|November 18, 2025
Optimization of Prodiginines as Single-Dose Curative AntimalarialsAmrendra Kumar, Yuexin Li, Xiaowei Zhang, et al.
Journal of Medicinal Chemistry|April 3, 2025
Development of Next-Generation Antimalarial Acridones with Radical Cure PotentialRozalia A Dodean, Yuexin Li, Xiaowei Zhang, et al.
Pageof 15